Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2017

24.10.2016 | Original Article

Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn’s Disease

verfasst von: Kyle Joshua Fortinsky, David Kevans, Judy Qiang, Wei Xu, Felipe Bellolio, Hillary Steinhart, Raquel Milgrom, Gordon Greenberg, Zane Cohen, Helen Macrae, Joanne Stempak, Robin McLeod, Mark S. Silverberg

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

The utility of postoperative medical prophylaxis (POMP) and the treatment of mild endoscopic recurrence remain controversial.

Methods

This study is a retrospective review of patients undergoing a primary ileocolic resection for CD at a single academic center. Endoscopic recurrence (ER) was defined using the Rutgeerts score (RS), and clinical recurrence (CR) was defined as symptoms of CD with endoscopic or radiologic evidence of neo-terminal ileal disease.

Results

There were 171 patients who met inclusion criteria. The cumulative probability of ER (RS ≥ i-1) at 1, 2, and 5 years was 29, 51, and 77 %, respectively. The only independent predictors of ER were the absence of POMP (HR 1.50; P = 0.03) and penetrating disease behavior (HR 1.50; P = 0.05). The cumulative probability of CR at 1, 2, and 5 years was 8, 13, and 27 %, respectively. There was a higher rate of clinical recurrence in patients with RS-2 compared to RS-1 on the initial postoperative endoscopy (HR 2.50; P = 0.02). In 11 patients not exposed to POMP with i-1 on initial endoscopy, only 2 patients (18 %) progressed endoscopically during the study period while 5 patients (45 %) regressed to i-0 on subsequent endoscopy without treatment.

Conclusions

Postoperative medical prophylaxis decreased the likelihood of ER while certain phenotypes of CD appear to increase the risk of developing ER and CR. There may be a role for watchful waiting in patients with mild endoscopic recurrence on the initial postoperative endoscopy.
Literatur
2.
Zurück zum Zitat Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46.e42–54.e42. (quiz e30).CrossRef Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46.e42–54.e42. (quiz e30).CrossRef
3.
Zurück zum Zitat Waterman M, Xu W, Stempak JM, et al. Distinct and overlapping genetic loci in Crohn’s disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2011;17:1936–1942.CrossRefPubMed Waterman M, Xu W, Stempak JM, et al. Distinct and overlapping genetic loci in Crohn’s disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2011;17:1936–1942.CrossRefPubMed
4.
Zurück zum Zitat Mikhailov TA, Furner SE. Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children. World J Gastroenterol. 2009;15:270–279.CrossRefPubMedPubMedCentral Mikhailov TA, Furner SE. Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children. World J Gastroenterol. 2009;15:270–279.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5:577–584.CrossRefPubMed Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5:577–584.CrossRefPubMed
6.
Zurück zum Zitat Baumgart DC, Sandborn WJ. Crohn’s disease. The Lancet. 2012;380:1590–1605.CrossRef Baumgart DC, Sandborn WJ. Crohn’s disease. The Lancet. 2012;380:1590–1605.CrossRef
7.
Zurück zum Zitat Regueiro MD. Update in medical treatment of Crohn’s disease. J Clin Gastroenterol. 2000;31:282–291.CrossRefPubMed Regueiro MD. Update in medical treatment of Crohn’s disease. J Clin Gastroenterol. 2000;31:282–291.CrossRefPubMed
9.
Zurück zum Zitat Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51–60.CrossRefPubMed Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51–60.CrossRefPubMed
10.
Zurück zum Zitat Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–1438.CrossRefPubMed Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–1438.CrossRefPubMed
11.
Zurück zum Zitat Romberg-Camps MJ, Dagnelie PC, Kester AD, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104:371–383.CrossRefPubMed Romberg-Camps MJ, Dagnelie PC, Kester AD, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104:371–383.CrossRefPubMed
12.
Zurück zum Zitat Cerqueira RM, Lago PM. Clinical factors predictive of Crohn’s disease complications and surgery. Eur J Gastroenterol Hepatol. 2013;25:129–134.CrossRefPubMed Cerqueira RM, Lago PM. Clinical factors predictive of Crohn’s disease complications and surgery. Eur J Gastroenterol Hepatol. 2013;25:129–134.CrossRefPubMed
13.
Zurück zum Zitat Pascua M, Su C, Lewis JD, et al. Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn’s disease. Aliment Pharmacol Ther. 2008;28:545–556.CrossRefPubMed Pascua M, Su C, Lewis JD, et al. Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn’s disease. Aliment Pharmacol Ther. 2008;28:545–556.CrossRefPubMed
14.
Zurück zum Zitat Olaison G, Smedh K, Sjodahl R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992;33:331–335.CrossRefPubMedPubMedCentral Olaison G, Smedh K, Sjodahl R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992;33:331–335.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665–672.CrossRefPubMedPubMedCentral Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665–672.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Vantrappen G, Rutgeerts P. Recurrence of Crohn’s lesions in the neoterminal ileum after ileal resection and ileocolonic anastomosis. Verh K Acad Geneeskd Belg. 1990;52:373–382. (discussion 383–385).PubMed Vantrappen G, Rutgeerts P. Recurrence of Crohn’s lesions in the neoterminal ileum after ileal resection and ileocolonic anastomosis. Verh K Acad Geneeskd Belg. 1990;52:373–382. (discussion 383–385).PubMed
17.
Zurück zum Zitat Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet. 1991;338:771–774.CrossRefPubMed Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet. 1991;338:771–774.CrossRefPubMed
18.
Zurück zum Zitat Cameron JL, Hamilton SR, Coleman J, et al. Patterns of ileal recurrence in Crohn’s disease. A prospective randomized study. Ann Surg. 1992;215:546–551. (discussion 551–552).CrossRefPubMedPubMedCentral Cameron JL, Hamilton SR, Coleman J, et al. Patterns of ileal recurrence in Crohn’s disease. A prospective randomized study. Ann Surg. 1992;215:546–551. (discussion 551–552).CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Buisson A, Chevaux JB, Allen PB, et al. Review article: the natural history of postoperative Crohn’s disease recurrence. Aliment Pharmacol Ther. 2012;35:625–633.CrossRefPubMed Buisson A, Chevaux JB, Allen PB, et al. Review article: the natural history of postoperative Crohn’s disease recurrence. Aliment Pharmacol Ther. 2012;35:625–633.CrossRefPubMed
20.
Zurück zum Zitat Ng SC, Lied GA, Arebi N, et al. Clinical and surgical recurrence of Crohn’s disease after ileocolonic resection in a specialist unit. Eur J Gastroenterol Hepatol. 2009;21:551–557.CrossRefPubMed Ng SC, Lied GA, Arebi N, et al. Clinical and surgical recurrence of Crohn’s disease after ileocolonic resection in a specialist unit. Eur J Gastroenterol Hepatol. 2009;21:551–557.CrossRefPubMed
21.
Zurück zum Zitat Rutgeerts P. Review article: recurrence of Crohn’s disease after surgery—the need for treatment of new lesions. Aliment Pharmacol Ther. 2006;24:29–32.CrossRefPubMed Rutgeerts P. Review article: recurrence of Crohn’s disease after surgery—the need for treatment of new lesions. Aliment Pharmacol Ther. 2006;24:29–32.CrossRefPubMed
22.
Zurück zum Zitat Ng SC, Kamm MA. Management of postoperative Crohn’s disease. Am J Gastroenterol. 2008;103:1029–1035.CrossRefPubMed Ng SC, Kamm MA. Management of postoperative Crohn’s disease. Am J Gastroenterol. 2008;103:1029–1035.CrossRefPubMed
23.
Zurück zum Zitat De Cruz P, Kamm MA, Prideaux L, et al. Postoperative recurrent luminal Crohn’s disease: a systematic review. Inflamm Bowel Dis. 2012;18:758–777.CrossRefPubMed De Cruz P, Kamm MA, Prideaux L, et al. Postoperative recurrent luminal Crohn’s disease: a systematic review. Inflamm Bowel Dis. 2012;18:758–777.CrossRefPubMed
24.
Zurück zum Zitat Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.CrossRefPubMedPubMedCentral Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963.CrossRefPubMed Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963.CrossRefPubMed
26.
27.
Zurück zum Zitat Gao X, Yang RP, Chen MH, et al. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn’s disease. Scand J Gastroenterol. 2012;47:1181–1191.CrossRefPubMed Gao X, Yang RP, Chen MH, et al. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn’s disease. Scand J Gastroenterol. 2012;47:1181–1191.CrossRefPubMed
28.
Zurück zum Zitat Regueiro M, Kip KE, Baidoo L, et al. Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence. Clin Gastroenterol Hepatol. 2014;12:1494–1502.CrossRefPubMed Regueiro M, Kip KE, Baidoo L, et al. Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence. Clin Gastroenterol Hepatol. 2014;12:1494–1502.CrossRefPubMed
29.
Zurück zum Zitat Lopez J, Konijeti GG, Nguyen DD, et al. Natural history of Crohn’s disease following total colectomy and end ileostomy. Inflamm Bowel Dis. 2014;20:1236–1241.CrossRefPubMedPubMedCentral Lopez J, Konijeti GG, Nguyen DD, et al. Natural history of Crohn’s disease following total colectomy and end ileostomy. Inflamm Bowel Dis. 2014;20:1236–1241.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kono T, Hida N, Nogami K, et al. Prospective postsurgical capsule endoscopy in patients with Crohn’s disease. World J Gastrointest Endosc. 2014;6:88–98.CrossRefPubMedPubMedCentral Kono T, Hida N, Nogami K, et al. Prospective postsurgical capsule endoscopy in patients with Crohn’s disease. World J Gastrointest Endosc. 2014;6:88–98.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Malireddy K, Larson DW, Sandborn WJ, et al. Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease. Arch Surg. 2010;145:42–47.CrossRefPubMed Malireddy K, Larson DW, Sandborn WJ, et al. Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease. Arch Surg. 2010;145:42–47.CrossRefPubMed
32.
Zurück zum Zitat Tursi A, Elisei W, Picchio M, et al. Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study. Tech Coloproctol. 2014;18:1041–1046.CrossRefPubMed Tursi A, Elisei W, Picchio M, et al. Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study. Tech Coloproctol. 2014;18:1041–1046.CrossRefPubMed
33.
Zurück zum Zitat Yamamoto T, Bamba T, Umegae S, et al. The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn’s disease: a 5-year prospective cohort study. United Eur Gastroenterol J. 2013;1:294–298.CrossRef Yamamoto T, Bamba T, Umegae S, et al. The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn’s disease: a 5-year prospective cohort study. United Eur Gastroenterol J. 2013;1:294–298.CrossRef
34.
Zurück zum Zitat Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. Am J Gastroenterol. 2013;108:1731–1742.CrossRefPubMed Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. Am J Gastroenterol. 2013;108:1731–1742.CrossRefPubMed
35.
Zurück zum Zitat Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn’s disease with mesalamine: European Cooperative Crohn’s Disease Study VI. Gastroenterology. 2000;118:264–273.CrossRefPubMed Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn’s disease with mesalamine: European Cooperative Crohn’s Disease Study VI. Gastroenterology. 2000;118:264–273.CrossRefPubMed
36.
Zurück zum Zitat McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology. 1995;109:404–413.CrossRefPubMed McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology. 1995;109:404–413.CrossRefPubMed
37.
Zurück zum Zitat Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002;51:405–409.CrossRefPubMedPubMedCentral Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002;51:405–409.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology. 1995;108:1617–1621.CrossRefPubMed Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology. 1995;108:1617–1621.CrossRefPubMed
39.
Zurück zum Zitat Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856–861.CrossRefPubMed Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856–861.CrossRefPubMed
41.
Zurück zum Zitat Schwartz M, Regueiro M. Prevention and treatment of postoperative Crohn’s disease recurrence: an update for a new decade. Curr Gastroenterol Rep. 2011;13:95–100.CrossRefPubMed Schwartz M, Regueiro M. Prevention and treatment of postoperative Crohn’s disease recurrence: an update for a new decade. Curr Gastroenterol Rep. 2011;13:95–100.CrossRefPubMed
42.
Zurück zum Zitat Kotze PG, Yamamoto T. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn’s disease: are all controversial issues defined? J Crohns Colitis. 2013;7:e698.CrossRefPubMed Kotze PG, Yamamoto T. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn’s disease: are all controversial issues defined? J Crohns Colitis. 2013;7:e698.CrossRefPubMed
43.
Zurück zum Zitat Armuzzi A, Felice C, Papa A, et al. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-label pilot study. J Crohns Colitis. 2013;7:e623–e629.CrossRefPubMed Armuzzi A, Felice C, Papa A, et al. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-label pilot study. J Crohns Colitis. 2013;7:e623–e629.CrossRefPubMed
45.
Zurück zum Zitat Cullen G, O’Toole A, Keegan D, et al. Long-term clinical results of ileocecal resection for Crohn’s disease. Inflamm Bowel Dis. 2007;13:1369–1373.CrossRefPubMed Cullen G, O’Toole A, Keegan D, et al. Long-term clinical results of ileocecal resection for Crohn’s disease. Inflamm Bowel Dis. 2007;13:1369–1373.CrossRefPubMed
46.
Zurück zum Zitat Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn’s disease. Gastroenterology. 1994;106:643–648.CrossRefPubMed Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn’s disease. Gastroenterology. 1994;106:643–648.CrossRefPubMed
47.
Zurück zum Zitat Simillis C, Jacovides M, Reese GE, et al. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum. 2010;53:177–185.CrossRefPubMed Simillis C, Jacovides M, Reese GE, et al. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum. 2010;53:177–185.CrossRefPubMed
48.
Zurück zum Zitat Simillis C, Yamamoto T, Reese GE, et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol. 2008;103:196–205.CrossRefPubMed Simillis C, Yamamoto T, Reese GE, et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol. 2008;103:196–205.CrossRefPubMed
50.
Zurück zum Zitat Caprilli R, Corrao G, Taddei G, et al. Prognostic factors for postoperative recurrence of Crohn’s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum. 1996;39:335–341.CrossRefPubMed Caprilli R, Corrao G, Taddei G, et al. Prognostic factors for postoperative recurrence of Crohn’s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum. 1996;39:335–341.CrossRefPubMed
51.
Zurück zum Zitat Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut. 1988;29:588–592.CrossRefPubMedPubMedCentral Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut. 1988;29:588–592.CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Vuitton L, Koch S, Peyrin-Biroulet L. Preventing postoperative recurrence in Crohn’s disease: what does the future hold? Drugs. 2013;73:1749–1759.CrossRefPubMed Vuitton L, Koch S, Peyrin-Biroulet L. Preventing postoperative recurrence in Crohn’s disease: what does the future hold? Drugs. 2013;73:1749–1759.CrossRefPubMed
53.
Zurück zum Zitat van Lent AU, D’Haens GR. Management of postoperative recurrence of Crohn’s disease. Dig Dis. 2013;31:222–228.CrossRefPubMed van Lent AU, D’Haens GR. Management of postoperative recurrence of Crohn’s disease. Dig Dis. 2013;31:222–228.CrossRefPubMed
54.
Zurück zum Zitat Cottone M, Orlando A, Viscido A, et al. Review article: prevention of postsurgical relapse and recurrence in Crohn’s disease. Aliment Pharmacol Ther. 2003;17:38–42.CrossRefPubMed Cottone M, Orlando A, Viscido A, et al. Review article: prevention of postsurgical relapse and recurrence in Crohn’s disease. Aliment Pharmacol Ther. 2003;17:38–42.CrossRefPubMed
Metadaten
Titel
Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn’s Disease
verfasst von
Kyle Joshua Fortinsky
David Kevans
Judy Qiang
Wei Xu
Felipe Bellolio
Hillary Steinhart
Raquel Milgrom
Gordon Greenberg
Zane Cohen
Helen Macrae
Joanne Stempak
Robin McLeod
Mark S. Silverberg
Publikationsdatum
24.10.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4351-7

Weitere Artikel der Ausgabe 1/2017

Digestive Diseases and Sciences 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.